An NR2B point mutation affecting haloperidol and Cp101,606 sensitivity of single recombinant N-methyl-D-aspartate receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 627-634

  Brimecombe, Jessica C ^a   Gallagher, Michael J ^b   Lynch, David R ^b   Aizenman, Elias ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; GLUTAMIC ACID; HALOPERIDOL; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECOMBINANT RECEPTOR; TRAXOPRODIL;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; NONHUMAN; PATCH CLAMP; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; ARGININE; CHO CELLS; CRICETINAE; DIZOCILPINE MALEATE; DOPAMINE ANTAGONISTS; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HALOPERIDOL; IODINE RADIOISOTOPES; PIPERIDINES; POINT MUTATION; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032428348     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Avenet P, Leonardon J, Besnard F, Graham D, Frost J, Depoortere H, Langer SZ and Scatton B (1996) Antagonist properties of the stereoisomers of ifenprodil at NR1A/ NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes. Eur J Pharmacol 296:201-213.
2. Béhé P, Stern P, Wyllie DJ, Nassar M, Schoepfer R and Colquhoun D (1995) Determination of NMDA NR1 subunit copy number in recombinant NMDA receptors. Proc R Soc Lon B Biol Sci 262:205-213.
3. Boeckman FA and Aizenman E (1994) Stable transfection of the NR1 subunit in Chinese hamster ovary cells fails to produce a functional N-methyl-D-aspartate receptor. Neurosci Lett 173:189-192.
4. Boeckman FA and Aizenman E (1996) Pharmacological properties of acquired excitotoxicity in Chinese hamster ovary cells transfected with N-methyl-D-aspartate receptor subunits. J Pharmacol Exp Ther 279:515-523.
5. Brimecombe JC, Boeckman FA and Aizenman E (1997) Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 94:11019-11024.
6. Burnashev N, Zhou Z, Neher E and Sakmann B (1995) Fractional calcium currents through recombinant GIuR channels of the NMDA, AMPA, and kainate receptor subtypes. J Physiol 485:403-418.
7. Carter C, Benavides J, Legendre P, Vincent JD, Noel F, Thuret F, Lloyd KG, Arbilla S, Zivkovic BJ, MacKenzie ET, Scatton B and Langer SZ (1988) Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II: Evidence for N-methyl-D-aspartate antagonist properties. J Pharmacol Exp Ther 247:1222-1232.
8. Chazot PL, Coleman SK and Cik M (1994) Molecular characterization of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule. J Biol Chem 269:24403-24409.
9. 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds. J Med Chem 34:3035-3090.
10. Chenard BL, Bordner J, Butler TW, Chambers LK, Collins MA, De Costa DL., Ducat MF, Dumont ML, Fox CB, Mena EE, Menniti FS, Nielson J, Pagnozzi MJ, Richter KEG, Ronau RT, Shalaby IA, Stemple JZ and White WF (1995) (1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A potent new neuroprotectant which blocks N-methyl-D-aspartate responses. J Med Chem 38: 3138-3145.
11. Cik M, Chazot PL and Stephenson FA (1993) Optimal expression of cloned NMDAR1/NMDAR2A heteromeric glutamate receptors: A biochemical characterization. Bochem J 296:877-883.
12. 3H]ifenprodil binding in rat brain membranes. J Pharmacol Exp Ther 280:584-592.
13. Ferrer-Montiel AV and Montai M (1996) Pentameric subunit stoichiometry of a neuronal glutamate receptor. Proc Natl Acad Sci USA 93:2741-2744.
14. Gallagher MJ, Huang H, Pritchett DB and Lynch DR (1996) Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem 271:9603-9611.
15. Gallagher MJ, Huang H, Grant ER and Lynch DR (1997) The NR2B-specific interactions of polyamines and protons with the N-methyl-D-aspartate receptor. J Biol Chem 272:24971-24979.
16. Gallagher MJ, Huang H and Lynch DR (1998) Modulation of the N-methyl-D-aspartate receptor by haloperidol: NR2B specific interactions. J Neurochem 70: 2120-2128.
17. Gotti B, Duverger D, Bertin J, Carter C, Dupont R, Frost J, Baudilliere B, MacKenzie ET, Rousseau J, Scatton B and Wick A (1988) Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I: Evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther 247:1211-1221.
18. Ilyin VI, Whittemore ER, Guastella J, Weber E and Woodward RM (1996) Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. Mol Pharmacol 50:1541-1550.
19. Kashiwagi K, Fukuchi J-I, Chao J, Igarashi K and Williams K (1996) An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons. Mol Pharmacol 49:1131-1141.
20. Kew JN, Trube G and Kemp JA (1996) A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurons. J Physiol 497:761-772.
21. 2+ block in NMDA receptors. J Neurosci 16:3549-3558.
22. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M and Mishina M (1992) Molecular diversity of the NMDA receptor channel. Nature 358:36-41.
23. Legendre P and Westbrook GL (1991) Ifenprodil blocks N-methyl-D-aspartate receptors by a two-component mechanism. Mol Pharmacol 40:289-298.
24. Luo J, Wang Y, Yasuda RP, Dunah AW and Wolfe BB (1997) The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol Pharmacol 51:79-86.
25. Lynch DR, Lawrence JJ, Lenz S, Anegawa NJ, Dichter M and Pritchett DB (1995) Pharmacological characterization of heterodimeric NMDA receptors composed of NR 1a and 2B subunits: Differences with receptors formed from NR1a and 2A. J Neurochem 64:1462-1468.
26. Lynch DR and Gallagher MJ (1996) Inhibition of N-methyl-D-aspartate receptors by haloperidol: Developmental and pharmacological characterization in native and recombinant receptors. J Pharmacol Exp Ther 279:154-161.
27. McIlhinney RAJ, Molnar E, Atack JR and Whiting PJ (1996) Cell surface expression of the human N-methyl-D-aspartate receptor subunit 1a requires the coexpression of the NR2A subunit in transfected cells. Neuroscience 70:989-997.
28. Monaghan DT and Larsen H (1997) NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology. J Pharmacol Exp Ther 280:614-620.
29. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B and Seeburg PH (1992) Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science 256:1217-1221.
30. Pahk AJ and Williams K (1997) Influence of extracellular pH on inhibition by ifenprodil at N-methyl-D-aspartate receptors in Xenopus oocytes. Neurosci Lett 225:29-32.
31. Premkumar LS and Auerbach A (1997) Stoichiometry of recombinant N-methyl-D-aspartate receptor channels inferred from single-channel current patterns. J Gen Physiol 110:485-502.
32. Sheng M, Cummings J, Roldan LA, Jan YN and Jan LY (1994) Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368:144-147.
33. Stern P, Béhé P, Schoepfer R and Colquhoun D (1992) Single-channel conductances of NMDA receptors expressed from cloned cDNAs: comparison with native receptors. Proc R Soc Lond B 250:271-277.
34. Stern P, Cik M, Colquhoun D, and Stephenson FA (1994) Single channel properties of cloned NMDA receptors in a human cell line: Comparison with results from Xenopus oocytes. J Physiol 476:394-397.
35. Wafford KA, Bain CJ, Le Bourdelles B, Whiting PJ and Kemp JA (1993) Preferential co-assembly of recombinant NMDA receptors composed of three different subunits. Neuroreport 4:1347-1349.
36. Whittemore ER, Ilyin VI and Woodward RM (1997) Antagonism of N-methyl-D-aspartate receptors by σ site ligands: Potency, subtype-selectivity and mechanisms of inhibition. J Pharmacol Exp Ther 282:326-338.
37. Williams K (1993) Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: Selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44:851-859.
38. Williams K, Zappia AM, Pritchett DB, Shen YM and Molinoff PB (1994) Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol Pharmacol 45:803-809.
39. Zhang S, Mott DD, Doherty J and Dingledine R (1997) The ifenprodil analogue, CP-101,606, inhibits NMDA receptors by enhancing proton inhibition. Soc Neurosci Abst 23:945.
40. Zhong J, Russell SL, Pritchett DB, Molinoff PB and Williams K (1994) Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons. Mol Pharmacol 45:846-853.